Brian Druker

Brian J. Druker, M.D. (born April 30, 1955) is a physician-scientist at Oregon Health & Science University (OHSU), in Portland, Oregon. He is the chief executive officer of OHSU's Knight Cancer Institute, JELD-WEN Chair of Leukemia Research, Associate Dean for Oncology in the [https://www.ohsu.edu/school-of-medicine OHSU School of Medicine], and professor of medicine.

Druker helped develop imatinib (Gleevec), the first medication that specifically targets cancer cells, for the treatment of chronic myeloid leukemia (CML). In 2001, Gleevec gained FDA approval in record time and landed on the cover of ''Time'' magazine. Druker’s work launched the era of precision cancer medicine, setting the stage for future discoveries in the quest to end cancer.

He is the recipient of the 2009 Lasker-DeBakey Clinical Medical Research Award, the 2012 Japan Prize in Healthcare and Medical Technology, the 2013 Albany Medical Center Prize in Medicine and Biomedical Research, and the 2019 Sjöberg Prize, among others. He has been called "Oregon's best-known scientist". Provided by Wikipedia
Showing 1 - 1 results of 1 for search 'Brian Druker', query time: 0.01s Refine Results
Search Tools: Get RSS Feed — Email this Search —